- As part of the round, Asia Partners co-founder Oliver Rippel and Novo Holdings Equity Asia senior partner Dr. Amit Kakar will join Doctor Anywhere’s board of directors.
- The company’s Series C, which it claims is one of the largest private rounds raised by a Southeast Asian healthtech company, brings its total funding to more than $140 million SGD. Doctor Anywhere’s omnichannel approach means that in addition to online consultations, it runs in-person clinics, provides home visits, medication deliveries and operates an in-app marketplace for health and wellness products.
- Lim told TechCrunch in an email that when he started working on Doctor Anywhere, there were already successful telemedicine platforms in the United States, the United Kingdom and China, but the model was still nascent in Southeast Asia.
[Via]
